Antisoma, a biotechnology company specializing in the development of novel drugs for the treatment of cancer, released a statement that the vaccine ASA404 improves anticancer responses and survival for patients with non-small cell lung cancer.

ASA404 is known as a vascular disrupting agent (VDA). ASA404 is different from angiogenenesis inhibitors that disrupt the new formation of blood vessels. This vaccine disrupts established blood vessels that feed cancer cells.

The researchers concluded that ASA404 appears promising in the treatment of advanced non-small cell lung cancer. A Phase III clinical trial is expected to begin in 2008. This is the last step prior to FDA review.

If you're in the mood for upping your antioxidant levels -- antioxidants can cancel out the cell-damaging effects of free radicals, thus lowering the risk of cancer -- here's one quick and easy tip for you: keep your watermelons warm.

Research shows that watermelons stored at room temperatures have much higher levels of antioxidants (beta-carotene and lycopene) than those kept chilled in the fridge. Warm watermelons are even better than fresh-picked melons.

One caution: once cut, watermelons must refrigerated. So try to enjoy your watermelons as soon as you slice and dice them. Then keep your leftovers cool.

Source: Good Housekeeping, July 2007

My sister has skin cancer -- the basal cell variety. She has two spots, both on her chest, each one scheduled to be surgically removed in a few weeks. If it were me with this new diagnosis, I'm sure I'd be freaking out, maybe because I've already had breast cancer and tend to panic about any cancer or maybe just because I'm a worrier by nature. But my sister is taking her cancer news in stride, and I am too -- because now that I've done a little research, it seems this type of cancer is pretty easy to beat.

Here's a little refresher lesson on the skin: The skin is the largest organ in the body, and is made of three layers -- the epidermis (top layer), dermis (middle layer), and subcutis (deepest layer). For the purpose of this post, let's focus on the epidermis.

The epidermis has three layers -- an upper, middle, and a bottom layer. This bottom layer is comprised of basal cells. This is where basal cell cancer begins.

I did a post back in August of last year about my friend Larissa's journey through breast cancer. Larissa was just recently diagnosed with cancer again. This time it was skin cancer, basal cell carcinoma.

I asked Larissa if she would talk about her experience and how it felt to be diagnosed with cancer yet again. Larissa blogs at Welcome to the Dallehouse.

How did you find out you had skin cancer?

I had a red patch on my face that didn't go away for several months. I kept an eye on it and noticed it was getting larger so I made an appointment with a dermatologist. The dermatologist thought it looked suspicious and did a shave biopsy. The biopsy came back positive for basal cell carcinoma.

Who knows which pieces of cancer information floating around out there are actually true? I don't. Do cell phones cause cancer? Some say yes, some say no, I say I'm confused! Luckily, I happened upon this Discovery Health article that highlights a variety of myths and then offers the lowdown on each one. Here are seven of them:

Myth #1. There is currently a cure for cancer, but the medical industry won't tell the public about it because they make too much money treating cancer patients.

Chalk this up to urban legend. And consider this: doctors, laboratory scientists, and their families and friends die of cancer at the same rate as everyone else in the United States. How about this: medical breakthroughs happen all the time and are quickly applied. Think about antibiotics and vaccines -- like the polio vaccine -- that have transformed health care. How about this? Not too long ago, less than one in 10 kids with leukemia survived 10 years. Now, the cure rate is nearly 80 percent. Seems like progress to me.

Tarceva (erlotinib) and Iressa (gefitnib) are both agents targeted against the EGFR pathway. This pathway is involved in cell growth and replication and when mutated or altered, excessive replication of cells can occur. These agents reduce the uncontrolled replication and growth of cancer cells by blocking mutated EGFR pathways.

According to an article published in the Journal of Clinical Oncology, the targeted agent Tarceva may provide anticancer responses for patients with non-small cell lung cancer (NSCLC) who stop responding to Iressa. These drugs are not associated with the side effects of chemotherapy, providing an effective alternative for patients who are not eligible for standard therapy.

A study was done to evaluate the effectiveness of Tarceva among patients who stopped responding to Iressa. The researchers concluded that -- Patients with NSCLC who demonstrate disease control with Iressa and do not have EGFR mutations appear to have benefit from treatment with Tarceva once their cancer progresses following their treatment with Iressa. Patients with recurrent NSCLC may wish to speak with their physician regarding their individual risks and benefits of treatment with Tarceva.

David Foster was diagnosed with Advanced Renal Cell Carcinoma in April 2005. Translation: stage four kidney cancer and the sixth deadliest form of cancer. Not a great disease to acquire. Also not the end of the world. Just ask David who is busy working as a National Strategic Advisor in Augusta, Georgia, headlining within the independent magazine community, hanging out with dog Gracie, and documenting his journey in a blog he calls David Foster's Kicking Kidney Cancer's Arse.

He's no wimp, this guy. Just read his June 23 post, titled May kill me, but it ain't gonna beat me. He didn't let that hard-nosed kid Jerry whip him when he was eight -- he smacked him so hard in the lunchroom, Jerry was left stumbling and bleeding -- and he won't let cancer bully him either. Still, David admits: he is sick. He explains it all in a post he calls Mr. Foster, are you really sick?

David got an e-mail one day. It read, Mr. Foster, are you really sick? I read your blog and you don't sound sick.

A report published in the Journal of the National Cancer Institute has stated that cisplatin has better response rates than carboplatin in the treatment of advanced non-small cell lung cancer.

The two main types of lung cancer, accounting for over 90 percent of all lung cancers, are non-small cell and small cell cancer. Non-small cell lung cancer (NSCLC) accounts for most of that 90 percent.

Advanced NSCLC means that the patient's cancer has spread to other organs or areas of the body. There has been research done to evaluate which drug is better for NSCLC -- cisplatin or carboplatin. Nine clinical trials were analyzed to see what regime is a better treatment option.

New cancer drug Torisol was approved on Wednesday by the FDA for use with renal cell carcinoma, an advanced form of kidney cancer.

Torisol, also known as temsirolimus, is an enzyme inhibitor made by Wyeth Pharmaceuticals and has shown promise for prolonging patient survival. It's the third kidney cancer drug approved in the past 18 months -- the other two are Nexavar, intended to delay disease progression, and Sutent, for tumor size reduction.

Many kidney cancer patients are cured by surgery. About 35 percent of patients, however, experience a recurrence or a spread of the disease. Until just recently, there were no effective drugs to control these issues. Now there are several -- and Torisol is the one showing modest improvement in survival for patients with the most advanced tumors. Further study will indicate whether or not the drug is useful for patients with less extensive metastatic disease.

Those who drink one or two cups of tea daily may have a lower risk of developing two types of skin cancer by 20 to 30 percent. In a study conducted on nearly 2,200 adults, researchers found that tea drinkers had a lower risk of developing squamous cell and basal cell carcinoma, the two most common forms of skin cancer.

The findings were published in the Journal of the American Academy of Dermatology.

Tea drinking did not show any effect on the worst skin cancer, melanoma. Still, the findings support the theory that tea antioxidants may limit the damage UV radiation inflicts on the skin, according to the study authors, led by Dr. Judy R. Rees of Dartmouth Medical School in Lebanon, New Hampshire.

The researchers do warn that it is not okay to bake in the sun and then have a cup of tea afterwards.

The study did not mention what specific types of teas might be more beneficial than others.

Mantle cell lymphoma is a type of Non-Hodgkins lymphoma. It is a cancer that forms in the cells of the lymph system. Mantle cell lymphoma is considered to be a low-grade and slow growing lymphoma.

The standard of care treatment is usually the chemotherapy combination called MCP, mitoxantrone, chlorambucil, and prednisolone.

The Journal of Clinical Oncology says that the addition of Rituxan (rituximab) to the chemo combination of MCP as initial therapy can improve long term survival rates.

Since Rituxan has proved to have anti-cancer responses in other forms of NHL, researchers continue to evaluate how it can work in the treatment of various types of Non-Hodgkins lymphoma.

If you find a new lump or spot on your skin, a sore that doesn't heal,or a change in a mole's appearance, it could be a sign of skin cancer.

• Basal cell skin cancer can look like a smooth, shiny, pale or waxy lump. It can be a lump that bleeds or develops a crust. Though this form of skin cancer rarely spreads to other parts of the body it can destroy nearby tissues.
• Squamous cell skin cancer can also look like a smooth, shiny, pale or waxy lump like basal cell. This form of skin cancer also rarely spreads to other parts of the body but it too can destroy nearby tissues.
• Melanoma skin cancer is the deadliest form and needs to be caught early. What to look for is asymmetry -- if one half of the mole looks different than the other half. If it has odd shaped borders and the color is not uniform throughout. Take a look at those moles and if you have any concerns seek out a dermatologist.

UVB radiation is thought to be the most dangerous light in the solar spectrum. Scientists think that UVB light causes most of the non-melanoma skin cancers.

When you're exposed to UVB radiation for a period of time, it inflames the skin and causes sunburn. Squamous cell carcinoma is diagnosed in about 250,000 people each year in the United States. The cancer can arise from the inflammation of the skin by possible DNA damage.

Even though the scientist's discovery was only so far seen in mice, the researchers at the Ohio State University Medical Center say that a topical compound made of black raspberries significantly slows the growth of Squamous cell skin cancer.

The scientists think that the cancer fighting effects are a result of powerful antioxidants called anthacyanins that give the fruit its rich, dark color. The researchers said "In our experiments, the black raspberry treatment significantly reduced inflammatory damage and reduced tumor growth and spread".

In the future the researchers hope to have a topical treatment for humans that will alleviate pain and also protect against sun damage.

Green peas are bursting with nutrients. They provide very good amounts vitamin K, vitamin C, vitamin B1 or thiamine, vitamin A vitamin B6, B3, and B2 and lots if dietary fiber, manganese, folate, phosphorus, magnesium, copper, iron, zinc and potassium. Green peas are that little food that is supercharged with nutritional and can supercharge your health.

Green peas are one of the important foods to include in your diet if you oftentimes feel fatigued and sluggish. That is because they provide nutrients that help support the energy-producing cells and systems of the body. They provide nutrients that are important for maintaining bone health. With its great source for iron green peas build normal blood cell formation and function. Low amounts of iron can result in anemia, fatigue, decreased immune function, and learning problems.

Vicki's Green Pea Salad
2 cups fresh green peas. (You can substitute with a 16 ounce package of frozen green peas. Rinse and thaw them for use in the salad.)
1 cup chopped fresh cauliflower ( make sure pieces are chopped about the same size as the peas.)
1 - 8 ounce can sliced water chestnuts (drain and rinse thoroughly and cut into strips)
1 - 8 ounce container sweet grape tomatoes or cherry tomatoes sliced in half
1/2 onion minced
1/2 cup chopped celery
1/2 cup mayonnaise
1/4 cup lemon juice
1 teaspoon dry dill

Whisk together the lemon juice, dill, and mayonnaise.
In large bowl mix all of the vegetables. Pour in the mayo and dill dressing and toss.

It's called triple-negative breast cancer and it manifests itself in the lack of expression of two cell surface proteins -- estrogen and progesterone receptors -- and also the protein HER2.

It's a disease that does not typically respond to treatment with standard chemotherapy drugs and therefore, diagnosis can come with a poor prognosis. But a new study out of Massachusetts General Hospital Cancer Center in Boston indicates this type of disease is sensitive to the drug cisplatin.

The study, appearing online in the April 19 Journal of Clinical Investigation and in the journal's May print issue, shows that triple-negative breast cancer expresses larger amounts of two proteins, delta-Np63 and TAp73. Delta-Np63 binds to TAp73 and prevents it from killing cancerous cells. Cisplatin does the trick, though, and releases TAp73 from delta-Np63. This causes the cells to die and offers hope for a sometimes hopeless disease.